EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H20N2 |
| Net Charge | 0 |
| Average Mass | 228.339 |
| Monoisotopic Mass | 228.16265 |
| SMILES | [H][C@@]12CCC[C@]1([H])c1cccc3c1N(CCNC3)C2 |
| InChI | InChI=1S/C15H20N2/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17/h1,3,6,12-13,16H,2,4-5,7-10H2/t12-,13-/m0/s1 |
| InChIKey | NPTIPEQJIDTVKR-STQMWFEESA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Applications: | antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| vabicaserin (CHEBI:754456) has role antipsychotic agent (CHEBI:35476) |
| vabicaserin (CHEBI:754456) is a benzodiazepine (CHEBI:22720) |
| INNs | Source |
|---|---|
| vabicaserin | WHO MedNet |
| vabicaserina | WHO MedNet |
| vabicaserine | WHO MedNet |
| Citations |
|---|